Skip to main content




Britain says it has offered COVID-19 vaccine to all over-50s

Britain says it has offered COVID-19 vaccine to all over-50s

FILE PHOTO: A man hands papers to a worker at a vaccination centre for the coronavirus disease (COVID-19) inside the Blackburn Cathedral, in Blackburn, Britain, January 19, 2021. REUTERS/Molly Darlington

LONDON: Britain on Monday (Apr 12) said it had offered all over-50s a first dose of COVID-19 vaccine, hitting a target to offer injections to all people in its nine highest priority groups by Apr 15.

Britain has seen one of the world's quickest vaccine rollouts, behind only Israel in the proportion of its population receiving at least one dose of a COVID-19 shot.

The government said it had offered at least one shot to priority cohorts 1 to 9, which include all adults over 50, the clinically vulnerable, and health and social care workers, ahead of Thursday's deadline.

"We have now passed another hugely significant milestone in our vaccine programme by offering jabs to everyone in the nine highest risk groups," Prime Minister Boris Johnson said in a statement.

"We will now move forward with completing essential second doses and making progress towards our target of offering all adults a vaccine by the end of July."

The success of the vaccine programme has underpinned Johnson's roadmap out of lockdown, which on Monday saw all shops and outdoor hospitality settings in England reopen.

But Britain has slowed down the pace of first doses, to ensure people in high-priority groups receive a second dose despite lower vaccine supplies in April than March.

Johnson's office said that the government remained on track to offer all adults a shot by Jul 31. People in their late 40s are expected to be the next to be invited for shots, though a final decision has not been made, his office said.

The Joint Committee on Vaccination and Immunisation (JCVI) has previously said that it expects to continue an age-based approach to the rollout, rather than prioritising people based on occupation or other risk factors.

Last week the JCVI also said it advised alternatives to AstraZeneca's vaccine for those under-30, given a very rare possible side effect of blood clots and the age group's low risk from COVID-19. 

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak:

Source: Reuters


Also worth reading